Capital International’s Tandem Diabetes Care TNDM Stock Holding History

Capital International’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,912	Closed	-$1.65M	–	159
2023 Q4	$1.65M	Sell	55,912 -1,077	-2%	-$22.3K	0.08%	145
2023 Q3	$1.18M	Sell	56,989 -1,048	-2%	-$28.8K	0.07%	145
2023 Q2	$1.42M	Hold	58,037	–	–	0.08%	148
2023 Q1	$2.36M	Buy	58,037 +5,731	+11%	+$237K	0.14%	135
2022 Q4	$2.35M	Buy	52,306 +7,218	+16%	+$327K	0.16%	130
2022 Q3	$2.16M	Buy	45,088 +10,485	+30%	+$575K	0.15%	128
2022 Q2	$2.05M	Sell	34,603 -15,066	-30%	-$1.24M	0.15%	121
2022 Q1	$5.78M	Buy	49,669 +371	+0.8%	+$43.3K	0.33%	89
2021 Q4	$7.42M	Buy	49,298 +12,969	+36%	+$1.75M	0.38%	75
2021 Q3	$4.34M	Sell	36,329 -361	-1%	-$39.8K	0.24%	104
2021 Q2	$3.57M	Sell	36,690 -400	-1%	-$35.7K	0.2%	115
2021 Q1	$3.27M	Sell	37,090 -420	-1%	-$39K	0.2%	114
2020 Q4	$3.59M	Buy	37,510 +21,093	+128%	+$2.17M	0.21%	105
2020 Q3	$1.86M	Buy	+16,417	New	+$1.72M	0.13%	121

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital International's TNDM Position: Q1 2024 in Review

Capital International sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 55,912 shares — an estimated $1.65M sold.

Capital International first reported a position in TNDM in Q3 2020 and held it in 14 quarters. The position peaked at $7.42M in Q4 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

Capital International reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
Capital International sold 55,912 Tandem Diabetes Care shares in Q1 2024, an estimated $1.65M.
Capital International first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 14 quarters.
Capital International's Tandem Diabetes Care position peaked at $7.42M in Q4 2021.
291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Capital International's 13F filing for Q1 2024, filed 14 May 2024.